Cargando…
Comparative antinociceptive effect of arachidonylcyclopropylamide, a cannabinoid 1 receptor agonist & lignocaine, a local anaesthetic agent, following direct intrawound administration in rats
BACKGROUND & OBJECTIVES: Treatment of inflammatory pain with opioids is accompanied by unpleasant and, at times, life-threatening side effects. Cannabis produces antinociception as well as psychotropic effects. It was hypothesized that peripheral cannabinoid receptors outside the central nervous...
Autores principales: | Kumar, Rahul, Prasoon, Pranav, Gautam, Mayank, Ray, Subrata Basu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393085/ https://www.ncbi.nlm.nih.gov/pubmed/28361827 http://dx.doi.org/10.4103/ijmr.IJMR_1402_15 |
Ejemplares similares
-
Role of fosaprepitant, a neurokinin Type 1 receptor antagonist, in morphine-induced antinociception in rats
por: Prasoon, Pranav, et al.
Publicado: (2016) -
Amyotrophic lateral sclerosis and anaesthetic challenges: Perioperative lignocaine infusion–an aid
por: Sarna, Rashi, et al.
Publicado: (2020) -
PM287. Mixtures of opioid receptor agonists and cannabinoid receptor agonists: enhanced antinociception without abuse liability
por: France, Charles P, et al.
Publicado: (2016) -
Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB(2) receptor agonist ABK5
por: Tang, Yaliang, et al.
Publicado: (2020) -
Comparison of Antinociceptive Effect of Octreotide With Morphine in a Rat
Model of Acute Inflammatory Pain
por: Singh, Perminder, et al.
Publicado: (2021)